Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTSS-2: Argatroban + rt-PA for Acute Stroke
NCT01464788Phase 2Terminated
- Start
- Oct 2011
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of argatroban in ischemic stroke (3 arms). Primary endpoints: Modified Rankin Scale Score 0-1 at 90 days and Symptomatic Intracranial Hemorrhage at 48 hours. Started Oct 2011; status: terminated.
02
Drugs
argatroban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01464788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01464788.